D-0114-2018 Class I Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-0114-2018 was initiated by Advanced Pharma Inc. on Jun 9, 2017 and is designated Class I. Reason for recall: Subpotent Drug: found to be below the specification for labeled assay. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 320 syringes.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2017
Initiation Date
Jun 9, 2017
Termination Date
Apr 3, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
320 syringes

Product description

NitroGlycerin (1 mg/5 mL) 1 mg in 5% Dextrose Inj, USP QS 5 mL (200 mcg per mL), 5 mL Sterile single dose syringe, packaged in 8 x 5 (FORTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-863-67.

Reason for recall

Subpotent Drug: found to be below the specification for labeled assay.

Distribution pattern

Nationwide in the USA to hospitals and medical facilities.

Code information

Lot: 4/10/17 1441 257-86367S, BUD 6/9/17; 4/17/17 0950 86367S, BUD¿6/16/2017; 4/20/17 1505 257-86367S, BUD 6/19/2017; 4/24/17 0115 15-86367S, BUD ¿6/23/2017; 4/26/17 0301 387-86367S, BUD 6/25/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0114-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0114-2018. Report a data issue: hello@regdatalab.com.